Medtronic plc
MDT · NYSE
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Revenue | $33,537 | $32,364 | $31,227 | $31,686 |
| % Growth | 3.6% | 3.6% | -1.4% | – |
| Cost of Goods Sold | $11,632 | $11,216 | $10,719 | $10,145 |
| Gross Profit | $21,905 | $21,148 | $20,508 | $21,541 |
| % Margin | 65.3% | 65.3% | 65.7% | 68% |
| R&D Expenses | $2,732 | $2,735 | $2,696 | $2,746 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $10,849 | $10,736 | $10,415 | $10,292 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2,369 | $2,533 | $1,912 | $2,751 |
| Operating Expenses | $15,950 | $16,004 | $15,023 | $15,789 |
| Operating Income | $5,955 | $5,144 | $5,485 | $5,752 |
| % Margin | 17.8% | 15.9% | 17.6% | 18.2% |
| Other Income/Exp. Net | -$327 | -$307 | -$121 | -$235 |
| Pre-Tax Income | $5,628 | $4,837 | $5,364 | $5,517 |
| Tax Expense | $936 | $1,133 | $1,580 | $456 |
| Net Income | $4,662 | $3,676 | $3,758 | $5,039 |
| % Margin | 13.9% | 11.4% | 12% | 15.9% |
| EPS | 3.63 | 2.77 | 2.83 | 3.75 |
| % Growth | 31% | -2.1% | -24.5% | – |
| EPS Diluted | 3.61 | 2.76 | 2.82 | 3.73 |
| Weighted Avg Shares Out | 1,286 | 1,328 | 1,330 | 1,342 |
| Weighted Avg Shares Out Dil | 1,290 | 1,330 | 1,333 | 1,351 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $729 | $719 | $636 | $553 |
| Depreciation & Amortization | $2,861 | $2,647 | $2,697 | $2,707 |
| EBITDA | $9,218 | $8,203 | $8,697 | $8,777 |
| % Margin | 27.5% | 25.3% | 27.9% | 27.7% |